Skip to content

Advertisement

  • Erratum
  • Open Access

Erratum to: Combined therapy with oncolytic adenoviruses encoding TRAIL and IL-12 genes markedly suppressed human hepatocellular carcinoma both in vitro and in an orthotopic transplanted mouse model

  • 1, 6Email author,
  • 1,
  • 2,
  • 3,
  • 1, 4,
  • 5,
  • 2,
  • 2 and
  • 2Email author
Journal of Experimental & Clinical Cancer Research201635:96

https://doi.org/10.1186/s13046-016-0365-4

  • Received: 25 May 2016
  • Accepted: 25 May 2016
  • Published:

The original article was published in Journal of Experimental & Clinical Cancer Research 2016 35:74

Erratum

Unfortunately, the original version of this article [1] contained an error. One of the subheadings within the “Methods” section read “Generation and purification of oncolytic adenoviruses expressing human TRAIL or human ING4 transgene”, but it should have read “Generation and purification of oncolytic adenoviruses expressing human TRAIL or human IL-12 transgene”.

This subheading has been also corrected in the original article.

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Laboratory Medicine, Faculty of Applied Medical Sciences, Umm Al-Qura University, PO Box 7607, Holy Makkah, Saudi Arabia
(2)
Department of Bioengineering, College of Engineering, Hanyang University, 222 Wangsinmi-ro, Seongdong-gu, Seoul, Korea
(3)
Graduate Program for Nanomedical Science, Yonsei University, Seoul, Korea
(4)
Department of Pathology, Faculty of Medicine, Umm Al-Qura University, Holy Makkah, Saudi Arabia
(5)
Science and Technology Unit & Department of Medical Genetics,Faculty of Medicine, Umm Al-Qura University, Holy Makkah, Saudi Arabia
(6)
Department of Pharmacology, Faculty of Medicine, Assiut University, Assiut, Egypt

Reference

  1. El-Shemi AG, Ashshi AM, Na Y, Li Y, Basalamah M, Al-Allaf FA, et al. Combined therapy with oncolytic adenoviruses encoding TRAIL and IL-12 genes markedly suppressed human hepatocellular carcinoma both in vitro and in an orthotopic transplanted mouse model. J Exp Clin Cancer Res. 2016;35(1):74. doi:10.1186/s13046-016-0353-8.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s). 2016

Advertisement